Research
Adherence
Pharmacological treatment of obesity is ineffective and potentially harmful if not combined with lifestyle changes (calorie restriction and increased energy expenditure), as evidenced by 'stop rules' that mandate discontinuation if <5% weight loss occurs within 12 weeks.
Obesity drugs are not magic. They require you to eat less and move more. If you don't see at least 5% weight loss in 3 months on the full dose, the drug isn't working for you, and you should stop and try something else. Always combine medication with lifestyle changes for the best results.
StrongConditionalMEDIUM confidence
Drug administration without calorie restriction and increased energy expenditure may result in less than 5% body weight loss after 12 weeks... If, after 12 weeks, there is less than 5% weight loss with full-dose therapy... the drug should be discontinued.
Why this rating
Based on clinical guidelines and trial protocols described in the review.
Source
Current pharmacological approaches in obesity treatment
Pelin TİRYAKİOĞLU et al. · DAHUDER Medical Journal · 2023
DOI 10.56016/dahudermj.1271677
narrative_reviewCited 2×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- GLP-1 receptor agonists (specifically liraglutide 3 mg/day) produce significant weight loss (8% mean reduction) and improve cardiovascular risk factors in obese and type 2 diabetic patients, though they carry a high discontinuation rate due to gastrointestinal side effects.Good
- Combination therapies (e.g., Phentermine/Topiramate, Naltrexone/Bupropion) offer superior weight loss compared to monotherapy by targeting multiple pathways (appetite suppression and calorie absorption/reward), but carry higher risks of adverse effects and require strict monitoring.Good
Related findings · Adherence
- Regular physical activity (at least 150 minutes/week of moderate-intensity) reduces all-cause and cardiovascular mortality by 20-30% and lowers the risk of type 2 diabetes by 25-35%.Strong
- Increasing physical activity from a sedentary lifestyle to an active one in middle adulthood significantly reduces the risk of coronary events compared to remaining sedentary.Strong
- Resistance exercise is the only intervention capable of consistently restoring muscle function and strength in sarcopenia, partially overcoming age-related anabolic resistance.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →